InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Shanafelt Armen, Director. Director active across 1 company, notably Aeglea BioTherapeutics, Inc.. Aggregated, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €394k. Activity tracked since 9 December 2021. The latest transaction was disclosed on 9 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Shanafelt Armen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
121,799 shares@ US$3.668100.0% of flowCommon StockSEC:0001209191-21-069351:0
Canonical exit: 9 Mar 2022 (T+90)
1 of 1 declaration
About Shanafelt Armen
Armen Shanafelt is a Board Member at Aeglea BioTherapeutics, Inc. He plays an important role in the governance of the company, bringing his expertise in the biopharmaceutical sector. His involvement helps Aeglea focus on innovation and sustainable growth while navigating a constantly evolving environment.
